Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SZSE:002864

Watchlist Manager
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Logo
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SZSE:002864
Watchlist
Price: 36.45 CNY -2.98% Market Closed
Market Cap: 3.9B CNY

Profitability Summary

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's profitability score is 51/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score
51/100
Profitability
Score

Margins

Earnings Waterfall
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Margins Comparison
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SZSE:002864
4B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.4B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.7B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SZSE:002864
4B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.4B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.7B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate